Chronic inflammation is linked to endothelial dysfunction and elevated prothrombin activity, and therefore, there is still a need to evaluate the impact of the adipokines in relation to various clinical outcomes of atherosclerosis so that these molecules could become great tools to predict the dynamics and therapeutic response of the disease. Here, F2 is linked to endothelial dysfunction.